|
|
Volumn 60 Suppl 4, Issue , 2003, Pages
|
|
Clinical and economic impact of nesiritide.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BRAIN NATRIURETIC PEPTIDE;
VASODILATOR AGENT;
CLINICAL TRIAL;
CONGESTIVE HEART FAILURE;
ECONOMICS;
EMERGENCY HEALTH SERVICE;
HEALTH ECONOMICS;
HOSPITAL;
HOSPITAL READMISSION;
HUMAN;
LENGTH OF STAY;
METHODOLOGY;
MORTALITY;
REVIEW;
STANDARD;
CLINICAL TRIALS;
ECONOMICS, HOSPITAL;
EMERGENCY MEDICAL SERVICES;
HEART FAILURE, CONGESTIVE;
HOSPITALS;
HUMANS;
LENGTH OF STAY;
NATRIURETIC PEPTIDE, BRAIN;
PATIENT READMISSION;
VASODILATOR AGENTS;
MLCS;
MLOWN;
|
|
EID: 0642373201
PISSN: 10792082
EISSN: None
Source Type: Journal
DOI: 10.1093/ajhp/60.suppl_4.s21 Document Type: Review |
|
Times cited : (6)
|
|
References (15)
|
